
Steve Booyens
About Steve Booyens
Steve co-founded Pearl Gray Equity and Research in 2020 and has been responsible for institutional equity research and PR ever since. Before founding the firm, Steve spent time working in various finance roles in London and South Africa. He holds an MSc in Investment Banking from Queen Mary – University of London and is working towards his Ph.D. in Finance, in which he’s attempting to challenge the renowned Fama-French 5-factor pricing model by incorporating ESG factors.
His articles are published on various reputable web pages such as Seeking Alpha, TipRanks, Yahoo Finance, and Benzinga. Steve’s articles on InvestorPlace form an interesting juxtaposition between mainstream opinion and objective theory. Readers can expect coverage on frequently traded stocks, cryptocurrencies, crowdfunding, and ETFs.

Join InvestorPlace Insights — FREE!
Get actionable advice from our top experts, including the hottest stocks to buy & sell, 401k and retirement tips, market analysis and more!
Recent Articles
5 Dividend Stocks to Buy For Yield-Hungry, Risk Tolerant Investors
High-yielding dividend stocks to buy are the go-to now. However, yields aren't always sustainable and the selection process is critical.
ARK Innovation Probably Won’t Recover
The ARK Innovation ETF isn't in great shape. This shouldn't be a surprise to investors, as the fund isn't backed by solid fundamentals.
Top 5 Oversold Chinese Stocks to Buy Before They Rebound
Despite Wall Street's hesitancy, there are still some great Chinese stocks to buy. Key metrics suggest that they're undervalued and worth it.
The Top 5 Dow Stocks to Buy Now
A few high-quality Dow stocks haven't been picked up yet, presenting lucrative buying opportunities for optimists.
Ginkgo Bioworks’ Animal-Free Eggs Make DNA Stock Enticing
Ginkgo's animal-free eggs deal with Evo food could be just what its overlooked stock needed to reach its full potential. DNA stock is a buy.